Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Investigational New Drugs|January 1, 1985
Mitoxantrone combined to vincristine, cyclophosphamide and fluorouracil in advanced breast cancerR Metz, M Delgado, R Keiling, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Tetracosactrin vs. methylprednisolone in the prevention of emesis in patients receiving FEC regimen for breast cancerJ Bonneterre, P Kerbrat, P Fargeot, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
A phase II study of pirarubicin in patients with advanced recurrent head and neck squamous cell carcinomaP H De Mulder, P Cappelaere, F Cognetti, et al.
Cancer Treatment Reports|June 1, 1986
Phase II clinical evaluation of doxifluridineP Hurteloup, J P Armand, P Cappelaere, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1985
Aminoglutethimide in advanced breast cancer: clinical results of a French multicenter randomized trial comparing 500 mg and 1 g/dayJ Bonneterre, H Coppens, L Mauriac, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase II study of pirarubicin (THP) in patients with cervical, endometrial and ovarian cancer: study of the Clinical Screening Group of the European Organization for Research and Treatment of Cancer (EORTC)J Chauvergne, P Fumoleau, P Cappelaere, et al.
Revue Francaise De Gynecologie Et D'Obstetrique|January 1, 1987
[Cancer of the ovary. Comparative value of serum CA-125, immunochemistry and biological tests of inflammation]P Gosselin, J L Cazin, J P Dehaut, et al.
American Journal of Clinical Oncology|April 1, 1994
Acute antiemetic efficacy and safety of dolasetron mesylate, a 5-HT3 antagonist, in cancer patients treated with cisplatin. European Dolasetron Study GroupT Conroy, P Cappelaere, M Fabbro, et al.
Bulletin Du Cancer|September 1, 1995
[Randomized placebo trial of myeloprotection with goralatide in patients with squamous cell carcinoma of the upper respiratory and digestive tracts or esophagus, treated with a carboplatin-fluorouracil combination]P Cappelaere, B Hecquet, F Rolland, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 1, 1997
A double-blind, multicentre comparison of intravenous dolasetron mesilate and metoclopramide in the prevention of nausea and vomiting in cancer patients receiving high-dose cisplatin chemotherapyB Chevallier, P Cappelaere, T Splinter, et al.
Pageof 7